15-day Sequential Therapy for Helicobacter Pylori Infection in Korea

NCT01887249 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

287

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Clarithromycin
DRUG: metronidazole
DRUG: esomeprazole

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]